��ֳ� celebrates World Intellectual Property Day

Vanco Vlastimil (��ֳ� S.A.) — Wed, 26 Apr 2023 08:06:37 +0000

Elise Melon, Global Legal Affairs

Vanco Vlastimi… Wed 26/04/2023 - 10:06

Every year, April 26 is the opportunity for innovators and creators around the world to reflect and highlight the many ways Intellectual Property (IP) impacts our lives. For ��ֳ�, IP is a cornerstone of our ambition to enable people living with severe diseases to live their best lives, now and in the future. The IP system has been playing an instrumental role in the development of many of the medicines that are available today, as well as future medicines, which are currently in our pipeline. This year the World Intellectual Property Organization (WIPO) has chosen to celebrate Women in Innovation and Creativity! Over the last few days we have been honored to hear the reflections of ��ֳ� colleagues on the importance of IP to spur and deliver innovation, on the importance of promoting equity, and critically, on the need to foster innovation for women.

At ��ֳ�, women represent over half of our total employees worldwide. We recognize the continuing need to promote equity and are striving to achieve this, including at executive level. As Iris Loew-Friedrich Executive Vice President and Chief Medical Officer, put it, “Equity is not a nice to have, it is a MUST have. Equity needs to be on our mind all the time, we need to value and embrace it in our thinking and actions.”

As pointed out by Marianne Fraiture, the Global Head of Diversity Equity & Inclusion, “In addition to our efforts to attract a diverse range of candidates, we developed the Empowered Females STEM Mentoring Program, to inspire the next generation of women to embark on a STEM (Science, Technology, Engineering & Mathematics) career. As an example, our gender diversity for gene therapy teams stands above the curve, with 47% of new hires being women compared to a market average of 33%.”

��ֳ� also aims at making a significant difference in supporting women living with chronic disease to live full, innovative, creative and productive lives (learn more at AdvantageHers.com). Women are underrepresented in clinical trials, which can negatively impact women's health. This is even more pronounced for pregnant and breastfeeding women: only 1.7% of clinical trials include pregnant women. ��ֳ� is committed to closing this gap in partnership with clinical teams, physicians, and patients around the world.

Our ambition is for our innovation to transform the lives of people living with severe diseases, and to that purpose, patients and their individual experiences are at the heart of everything we do, including in our approach to IP. At ��ֳ�, we believe our ability to deliver innovative solutions to patients, now and into the future, and in a way which is sustainable for ��ֳ�, for patients and for society can only be supported by a responsible vision and practice of IP, guided by patient and societal value. Discover our approach to IP here.

On this World IP Day, we hope you will join us in celebrating the role of intellectual property in creating patient value and the women and men who push beyond the boundaries of what’s possible and help us shape the future and deliver hope for new solutions.

about ucb

446 Likes

The IP PACT: Our commitment to putting patients at the heart of our approach to IP

eCMSadmin — Mon, 26 Apr 2021 09:00:00 +0000

The IP PACT: Our commitment to putting patients at the heart of our approach to IP

Elise Melon, Intellectual Property Policy ＆ Operations

eCMSadmin Mon 26/04/2021 - 11:00

World IP Day on April 26 is a time for us to reflect on the importance of intellectual property (IP) as a cornerstone of biopharmaceutical innovation.

IP has been and remains a critical enabler of ��ֳ�’s ambition to transform the lives of people living with severe diseases. It is key to our ability to deliver on the fundamental commitment we made to enabling people living with severe diseases, their caregivers and their families to live their best lives. Without IP, ��ֳ� would be unable to continuously innovate and bring differentiated solutions with unique outcomes to help specific patients achieve their life goals.

And that is precisely why ��ֳ� is proud to be among a group of around 30 leading innovative biopharmaceutical companies that have come together to launch a series of IP Principles for Advancing Cures and Therapies – or the IP PACT for short.

The IP PACT is a groundbreaking declaration affirming our companies’ strong commitment to putting patients at the heart of our approach to IP. For the first time, companies like ours come together to explain and openly set forth the principles that outline how we use the IP system.

The first principle captures the essence and the commitment behind all of them: our core purpose of bringing value to patients and society must guide our approach to IP.

Being part of the IP PACT is yet another embodiment of our commitment to putting patients at the heart of everything we do. It further reflects our commitment to both current and future generations.

To ensure we achieve that goal, sustainability is an imperative which applies to our IP Practice in the same way it applies to every other aspect of our business.This means that in any decision we make, we ask ourselves how we can make the biggest difference for our current patients while preserving our ability to invest and take risks in the long term to meet the needs of future generations.

I ask you to join us in celebrating #WorldIPDay today. Let’s recognise the critical role IP plays in medical progress and allowing patients to live their best lives.

about ucb

World IP Day IP PACT Intellectual property

691 Likes

Intellectual property

��ֳ� celebrates World Intellectual Property Day

Leave a Comment

The IP PACT: Our commitment to putting patients at the heart of our approach to IP

Leave a Comment

Intellectual property

������ֳ� celebrates World Intellectual Property Day

Leave a Comment

The IP PACT: Our commitment to putting patients at the heart of our approach to IP

Leave a Comment

��ֳ� celebrates World Intellectual Property Day